Analysis of Medtronic Stent Finds Early Cessation of Dual Antiplatelet Therapy

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy

Filed under: minneapolis

MINNEAPOLIS and MIAMI — Oct. 22, 2012 — Interrupting dual antiplatelet therapy after 30 days following the implantation of a Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) caused no increase in rates of stent thrombosis at one year …
Read more on Reuters

 

Tests Find Bacteria in Products of Mass. Pharmacy

Filed under: drug addiction treatment minneapolis

The U.S. Food and Drug Administration said it doesn't yet know the significance of the bacterial contamination discovered in recalled New England Compounding Center products. Some of the bacteria found are rarely cited as a cause of disease in humans.
Read more on KSTP.com

 

Medtronic Completes Enrollment in Landmark Study of IN.PACT Drug-Eluting

Filed under: drug addiction treatment minneapolis

Oct 5, 2012 — Minneapolis — Committed to researching treatments for peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced that patient enrollment in a landmark study of its IN.PACT Amphirion drug-eluting balloon is complete, with …
Read more on Angioplasty.Org

 


Tags: , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *